Anti-VEGFR2 treatment increased CXCL12/CXCR4 expression in orthotopic CRC models and conditional Apc mutant spontaneous rectal tumors (Jung et al., 2017). The gene discussed is CXCL12; the disease is colorectal carcinoma.